Dr Rahul P. Sharma, MBBS, FRACP is the Director of Structural Interventions at Stanford Healthcare and Clinical Assistant Professor of Medicine at Stanford University.

Dr Sharma graduated from Monash University and completed his medicine and cardiology training at the Alfred Hospital in Melbourne, Australia. He completed an advanced interventional and structural fellowship at Cedars Sinai Medical Center in Los Angeles, California in 2015 before joining Cedars Sinai as Clinical Faculty, Director of the Structural Imaging Core Laboratory and Associate Director of Interventional Cardiology Research until 2019, before joining Stanford Healthcare.

Dr Sharma is an Interventional Cardiologist with specialized clinical and research interests in structural heart disease, particularly transcatheter valve therapy. He has a large volume of expertise in transcatheter aortic, mitral and tricuspid replacement, percutaneous mitral valve repair, left atrial appendage occlusion, PFO/ASD/VSD closure, alcohol septal ablation and cerebral protection. He also has expertise in CT imaging for structural heart disease. He is a clinical investigator in ongoing national multi-center research studies and clinical trials and has co-authored numerous peer reviewed, scientific articles and book chapters. Dr Sharma also serves as a national and international clinical proctor for transcatheter aortic and mitral valve implantation and percutaneous mitral valve repair and speaks regularly at major national and international cardiology meetings.

Dr. Sharma is the CEO of Texas Cancer Associates in Dallas, Texas and has been a member of the clinical faculty, practicing at Presbyterian Hospital of Dallas since 1993. In addition, he is CEO of HealthIT, Inc. — an internet services company, supporting the patient/provider network with technology solutions. He is also the founder of NexGen Oncology, bringing next generation cancer care to the oncology field and other practices by providing solutions for the diagnosis, management, and treatment of cancer.

‍

Dr. Sharma is Texas trained and graduated from the University of Texas at Arlington with a B.S. in Biology in 1983. He completed his medical education at the University of Texas Medical Branch in Galveston, Texas in 1987. Following an internship and residency at the University of Texas Health Sciences Center in San Antonio, Dr. Sharma was instructor and clinical fellow of medical oncology at the same institution. He is board certified in internal medicine and medical oncology.

As an oncologist, Dr. Sharma has been at the forefront of cancer research, working to accelerate the delivery of new drugs from the “bench to the bedside.” His publications include medical oncology-related articles in peer-reviewed journals such as the Journal of the National Cancer Institute as well as articles relating to healthcare technology including those published in The Dallas County Medical Society Journal and Oncology Issues. In addition, Dr. Sharma has co-authored an industry report for the Financial Times of London on E-Business for the pharmaceutical industry.

As a leader in the healthcare and technology fields, Dr. Sharma has received numerous honors for his industry leadership, teaching efforts and dedication to patient care. He has been voted “Best Doctors in Dallas” by his peers on multiple occasions and included in the “Winner’s Circle of Best Doctors in Dallas” (D Magazine, 2004). He has served on the Medical Board, Presbyterian Hospital Dallas from 1999 to 2001 and as Chair, MIS Council Texas Health Resources in 2001.

He is a presenter/speaker to various medical groups and organizations on topics ranging from cancer treatments to advanced medical technologies. Dr. Sharma is a member of the American Medical Association (AMA), the American Medical Informatics Association (AMIA), the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), the College of Health Information Management Executives (CHIME), Health Information Management Systems Society (HIMSS), and the American College of Physician Executives (ACPE).

‍

Born in Amritsar, India, Dr. Sharma is fluent in Hindi and Punjabi as well as English and Spanish and has studied German, French, Latin, and Sanskrit. Dr. Sharma is an advocate of best patient care practices, education, innovation, and in making meaningful, individual contributions that make an impact on the societies in which we live.

Kevin M. Sheridan is a retired Supervisory Special Agent, who served the Federal Bureau of Investigation at the FBI Washington D.C., Miami, Dallas, and El Paso field offices and FBI Headquarters. Mr. Sheridan maintains FBI Top Secret (TS) security clearance.

Special Agent Sheridan managed and supervised large-scale, high-profile, and sensitive federal investigations with a particular focus on white-collar offenses (e.g. financial crimes and healthcare fraud) as well as matters of national security, CIA/FBI counterintelligence, and aviation security. Mr. Sheridan offers corporate and individual clients two decades of frontline leadership experience specifically when it comes to Medicare, Medicaid, workers’ compensation, and private insurance healthcare fraud enforcement and compliance.

Tasked to implement President Obama’s National Directive to fight healthcare fraud, Mr. Sheridan was one of the architects of forming Medicare Fraud Strike Force teams consisting of specialized agents from the FBI, the Department of Health and Human Services (HHS-OIG), the Medicaid Fraud Control Unit (MFCU), as well as specifically selected Justice Department prosecutors. As the supervisor of the FBI Healthcare Fraud Squad, Special Agent Sheridan was the lead agent on the investigation of Dr. Jacques Roy, the largest healthcare fraud prosecution of a single physician in U.S. history amounting to $450 million.

Assigned to the FBI’s Washington D.C. office, Special Agent Sheridan served as the primary investigator in FBI Major Case 133, codenamed “CAMPCON”, involving the 1996 Presidential Election Campaign centered on President Clinton and the Democratic National Committee. In this capacity, Mr. Sheridan testified before the Governmental Affairs Committee of the U.S. He worked closely with other members of the intelligence community.

Mr. Sheridan graduated with honors in accounting from Eastern New Mexico University before joining Ernst & Young as a tax accountant. Mr. Sheridan served in the United States Air Force and achieved the rank of Sergeant before receiving a United States Army Reserve commission and served as a Captain/Air Defense Officer.

Roger J. Bach offers clients 30 years of Department of Justice, healthcare fraud, and federal criminal law enforcement experience. Mr. Bach is a former Office of Professional Responsibility (OPR) Inspector, former OIG Special Agent, former Supervisory Special Agent, former Executive Assistant to the New York DEA Special Agent-in-Charge, and a former Criminal Investigator with the Attorney General’s Medicaid Fraud Control Unit (MFCU).

As a U.S. Department of Justice, Special Agent for the Office of Inspector General, Mr. Bach conducted a plethora of federal criminal investigations throughout the United States. Mr. Bach worked closely with other agencies such as the FBI, OPR, and the Department of Homeland Security to investigate public corruption, bribery, money laundering, federal fraud and abuse, false statements, federal theft, and federal program fraud cases. Mr. Bach testified before state and federal grand juries and at trials across the United States. His Top-Secret Clearance allowed him to lead and have access to matters of national security including counterterrorism, counterintelligence, and classified sensitive data.

Mr. Bach has substantial experience with healthcare fraud investigations. On behalf of the Attorney General and with Top-Secret Clearance, Mr. Bach conducted criminal healthcare fraud cases involving the Medicaid program as part of the Medicaid Fraud Control Unit (MFCU). Mr. Bach investigated dentists, physicians, psychiatrists, psychologists, and therapists for billing fraud, medically unnecessary procedures and services, fraudulent claims submissions, and other forms of Medicaid Fraud in the rank of a Sergeant and Criminal Investigator—a valuable experience now offered to those medical providers under audit or investigation.

With Top-Secret Clearance, Mr. Bach coordinated complex financial crime investigations involving wire fraud, money laundering, money tracing, drug trafficking, and large federal conspiracy cases at the U.S. Attorney’s Office for the Southern and Eastern Districts of New York, Department of Justice, first as a Special Agent, then as a Supervisory Special Agent, and ultimately as the Executive Assistant for the Special Agent-in-Charge. Appointed as head of the Long Island, New York DEA Task Force, Mr. Bach served as a liaison for the U.S. Attorney’s Offices in Manhattan and Brooklyn, as well as the managing supervisor for classified domestic and international Title III operations.

Mr. Bach offers his extensive healthcare fraud and OIG federal law enforcement experience to clients under audit, under investigation, or formally accused by the OIG, the FBI, the U.S. Attorney’s Office, the Medicaid Fraud Control Unit, the Justice Department, or other federal agencies in cases involving Medicare Fraud, Medicaid Fraud, healthcare billing fraud, insurance fraud, money laundering, wire fraud, mail fraud, tax fraud, and other financial offenses. A significant portion of Mr. Bach’s services include compliance reviews and assessments, corporate internal investigations and healthcare audits, as well as developing and coordinating effective defense strategies in federal fraud cases.

Mr. Bach is a TCOLE Certified Peace Officer with a Master’s degree in Public Administration. Prior to joining the U.S. Department of Justice, Mr. Bach was a Criminal Investigative Division Detective and Sergeant in Florida.

My dream job throughout college was to become a Molecular Technologist in a highly accredited laboratory, and that dream came true thanks to AmeriHealth. Ever since I can remember, I’ve had a deep passion for genetics; it has always been so interesting to me.

I’m from a very small town in Indiana where I graduated from Purdue University with a Bachelor's degree in biology with a genetics concentration, as well as an Associates degree in chemistry. Throughout college, I was a part of a research team that specialized in Nutraceuticals. The focus of our research was to help reduce stress in fish, but also to see if the benefits translated to humans as well. After college, I got married to my high-school sweetheart and made the big decision to leave our small town and move to Dallas Texas to pursue our careers.

Jose Garcia is a Dallas Texas Native, bornand raised only 15 min. away from our lab. He is a graduate of Tarleton StateUniversity where he earned a Bachelor’s in Biomedical Science with a concentrationin Human Medicine as a Pre-Med student. He is currently finishing up his lastsemester of his master’s program as a graduate student at Tarleton StateUniversity, in Medical Lab Science with a concentration in Molecular Diagnosticsand will obtain his board certification from the American Society for ClinicalPathology at the end of the semester. During those years at Tarleton StateUniversity he was part of the Alpha Epsilon Delta society for healthpre-professional program, and the biology club. Jose hopes to one day attendmedical school to follow his life goal of becoming a cardiothoracic surgeon.

During his time at Tarleton State UniversityJose learned and perfected a variety of clinical and molecular lab skills suchas Enzyme-linked immunosorbent assay (ELISA), Gel electrophoresis, bloodagglutinations, western blots, Polymerase Chain Reaction (PCR), Next GenSequencing, histology staining, among others. Before working with us Jose wasworking as a lab technician at Cain Food Industries doing analytical chemistrywork. During his time at Cain Food Industries he became very well verse indifferent areas of the lab as he did lab bench work gaining a lot of experiencewith High Performance Liquid Chromatography (HPLC), as well as addressingcustomer questions and creating/sending certificates of authenticity.

Jose loves watching medical drama showslike Grey’s Anatomy. He also has a love for competitive swimming and diving inwhich he has participated for many years. Jose has had CPR and First aidtraining/certification while working as a lifeguard during his summers as astudent. Oh, and don’t forget Jose listens to country music non-stop!

I am an ASCP-certified Medical Laboratory Scientist with over 12years of diagnostic testing experience in the Molecular lab. I am skilled insupervising, and operating CLIA-approved laboratories. In my current positionas Senior Assay Development Scientist at Progenity, I design, develop,andvalidate various diagnostic assays for detection of cancers, chronicinflammatory gastrointestinal disorders, and infectious diseases. I have beenhelping several DFW companies in development and validation of assays inmicrobiology, molecular microbiology, pharmacogenetics and cancer since 2017.

My research focus during my PhD and postdoctoral careers was onHIV-1 infection of the central nervous system, transcriptional reprogramming ofHIV-infected CD4 T cells, and discovery of novel small molecule re-activatorsof HIV-1 latency. I have published in the Progress in Neurobiology Journal, theJournal of Neurovirology, and the journal of Neuroinflammation.

As an experienced technical supervisor of molecular clinicallaboratory, I have expertise in directing and overseeing daily operations,development of molecular diagnostic assays for pathogen identification, andvalidation of different testing platforms. Aside from my duties in the clinicallab, I am dedicated to training the new generations of medical laboratoryscientists at Tarleton State University’s Medical Laboratory Science programwhere I have been teaching medical genetics, immunology, microbiology,parasitology, and molecular microbiology courses since 2016.

Very early on, I developed a passion forhelping families with special health care needs. After completing myundergraduate degree in Biology from Dallas Baptist University, I entered excitingand ever-growing field, that is molecular diagnostics. Currently, I am workingon completing my master’s in Medical Laboratory Science at Tarleton StateUniversity. Upon my completion, I will be attaining my Molecular Biologycertification through ASCP.

I joined the AmeriHealth Laboratory familyin 2020 as a Medical Molecular Technologist, and I could not be prouder of thework that we do for our patients. In the lab, I perform molecular testing forcancer predisposition. When I am not working in the lab and helping getaccurate results in a timely manner, I am a professional wedding photographerwho enjoys capturing lifelong moments on most weekends.

Current Master of Science candidate at Tarleton State Universitywith a focus on molecular diagnostics. My education is in molecular pathologyand molecular laboratory techniques with the goal of becoming a certified inMolecular Biology (MB) through the American Society for Clinical Pathology(ASCP). My master's thesis research project aims to elucidate the origin of thenovel mesenchymal osteoproginator cells leading to the normal development ofbone in the scales of the American alligator. I hope that the results from thisstudy can be applied to the human disease Heterotopic Ossification (HO) andhighlight the American alligator as a promising new animal model that can beutilized to further the understanding of HO development.

Lauren is originally from Montana but fellin love with Southern Methodist University where she became a researchassistant in a health psychology lab and the president of the American CancerSociety at SMU. She has recently become an SMU 2020 graduate with a Bachelor ofScience in Biology and a Bachelor of Art in Spanish. Her future plans includeattending medical school in San Antonio so she can further develop her love ofmedicine and Spanish.

Alexa is an Orange County California nativewho has resided in Dallas for the past 4 years. Alexa is a recent graduate fromSMU with a Bachelor of Science in Biology and a double minor in Neuroscienceand Cognitive Science. She is a published research assistant whose main studiesfocused on exploring the impacts of RNA binding protein combinations inneuronal function and organismal behavior in C. elegans. Outside of herundergrad research, she has had experience in various lab settings such asmolecular genetics and microbiology in which she has gained proficiency in gelelectrophoresis and PCR. Alexa has future aspirations of becoming aneuroscientist focusing on neurodegenerative diseases in humans.

After graduating with a BS in Biology with an emphasis in Molecular and Cellular studies from UTD, I’ve immersed myself into a field of Infectious Diseases to better serve my surrounding community through active engagement. I have always enjoyed laboratory settings and understanding the processes of finding the unique characteristics of diseases, pathogens, and genetic variations that affect our everyday living.

‍
My true passion lies within animal health and care, and gaining knowledge of molecular diagnostics for human use, I hope will allow for a cross-over to animal use that promotes healthier long-term care for endangered animals and those under stressed living ecosystems.